A prospective study of Tralokinumab among moderate-severe atopic dermatitis patients with inadequate response to Dupilumab
Latest Information Update: 17 Jan 2025
Price :
$35 *
At a glance
- Drugs Tralokinumab (Primary) ; Corticosteroids
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- 17 Jan 2025 New trial record